MRC1
Macrophage mannose receptor 1
Also known as: bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1_HUMAN, MRC1L1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P22897
- Gene
- MRC1
- Ensembl
- ENSG00000260314
- Chromosome
- 10
- Canonical length
- 1456 aa
- Protein class
- CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins
OverviewNCBI Gene
The recognition of complex carbohydrate structures on glycoproteins is an important part of several biological processes, including cell-cell recognition, serum glycoprotein turnover, and neutralization of pathogens. The protein encoded by this gene is a type I membrane receptor that mediates the endocytosis of glycoproteins by macrophages. The protein has been shown to bind high-mannose structures on the surface of potentially pathogenic viruses, bacteria, and fungi so that they can be neutralized by phagocytic engulfment.[provided by RefSeq, Sep 2015]
Canonical amino-acid sequenceUniProt
1456 residues, UniProt reviewed canonical sequence.
>P22897|MRC1
1 MRLPLLLVFA SVIPGAVLLL DTRQFLIYNE DHKRCVDAVS PSAVQTAACN QDAESQKFRW
61 VSESQIMSVA FKLCLGVPSK TDWVAITLYA CDSKSEFQKW ECKNDTLLGI KGEDLFFNYG
121 NRQEKNIMLY KGSGLWSRWK IYGTTDNLCS RGYEAMYTLL GNANGATCAF PFKFENKWYA
181 DCTSAGRSDG WLWCGTTTDY DTDKLFGYCP LKFEGSESLW NKDPLTSVSY QINSKSALTW
241 HQARKSCQQQ NAELLSITEI HEQTYLTGLT SSLTSGLWIG LNSLSFNSGW QWSDRSPFRY
301 LNWLPGSPSA EPGKSCVSLN PGKNAKWENL ECVQKLGYIC KKGNTTLNSF VIPSESDVPT
361 HCPSQWWPYA GHCYKIHRDE KKIQRDALTT CRKEGGDLTS IHTIEELDFI ISQLGYEPND
421 ELWIGLNDIK IQMYFEWSDG TPVTFTKWLR GEPSHENNRQ EDCVVMKGKD GYWADRGCEW
481 PLGYICKMKS RSQGPEIVEV EKGCRKGWKK HHFYCYMIGH TLSTFAEANQ TCNNENAYLT
541 TIEDRYEQAF LTSFVGLRPE KYFWTGLSDI QTKGTFQWTI EEEVRFTHWN SDMPGRKPGC
601 VAMRTGIAGG LWDVLKCDEK AKFVCKHWAE GVTHPPKPTT TPEPKCPEDW GASSRTSLCF
661 KLYAKGKHEK KTWFESRDFC RALGGDLASI NNKEEQQTIW RLITASGSYH KLFWLGLTYG
721 SPSEGFTWSD GSPVSYENWA YGEPNNYQNV EYCGELKGDP TMSWNDINCE HLNNWICQIQ
781 KGQTPKPEPT PAPQDNPPVT EDGWVIYKDY QYYFSKEKET MDNARAFCKR NFGDLVSIQS
841 ESEKKFLWKY VNRNDAQSAY FIGLLISLDK KFAWMDGSKV DYVSWATGEP NFANEDENCV
901 TMYSNSGFWN DINCGYPNAF ICQRHNSSIN ATTVMPTMPS VPSGCKEGWN FYSNKCFKIF
961 GFMEEERKNW QEARKACIGF GGNLVSIQNE KEQAFLTYHM KDSTFSAWTG LNDVNSEHTF
1021 LWTDGRGVHY TNWGKGYPGG RRSSLSYEDA DCVVIIGGAS NEAGKWMDDT CDSKRGYICQ
1081 TRSDPSLTNP PATIQTDGFV KYGKSSYSLM RQKFQWHEAE TYCKLHNSLI ASILDPYSNA
1141 FAWLQMETSN ERVWIALNSN LTDNQYTWTD KWRVRYTNWA ADEPKLKSAC VYLDLDGYWK
1201 TAHCNESFYF LCKRSDEIPA TEPPQLPGRC PESDHTAWIP FHGHCYYIES SYTRNWGQAS
1261 LECLRMGSSL VSIESAAESS FLSYRVEPLK SKTNFWIGLF RNVEGTWLWI NNSPVSFVNW
1321 NTGDPSGERN DCVALHASSG FWSNIHCSSY KGYICKRPKI IDAKPTHELL TTKADTRKMD
1381 PSKPSSNVAG VVIIVILLIL TGAGLAAYFF YKKRRVHLPQ EGAFENTLYF NSQSSPGTSD
1441 MKDLVGNIEQ NEHSVILocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 115 nTPM
Expression across tissuesHPA
Tissue
- lung: 115 nTPM
- placenta: 51 nTPM
- adipose tissue: 51 nTPM
- spleen: 48 nTPM
- liver: 38 nTPM
- smooth muscle: 28 nTPM
Single-cell type
- breast lactating cells: 1,706 nCPM
- macrophages: 1,041 nCPM
- kupffer cells: 996 nCPM
- hofbauer cells: 549 nCPM
- cdc: 481 nCPM
- lymphatic endothelial cells: 408 nCPM
Immune cell
- myeloid DC: 4.8 nTPM
- classical monocyte: 0.3 nTPM
- T-reg: 0.2 nTPM
- memory CD4 T-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- total PBMC: 0.1 nTPM
Brain region
- choroid plexus: 20 nTPM
- cerebral cortex: 8 nTPM
- thalamus: 7.4 nTPM
- basal ganglia: 4.1 nTPM
- medulla oblongata: 3.4 nTPM
- pons: 3.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.94
- gnomAD missense Z
- 1.95
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to interleukin-4
- cellular response to lipopolysaccharide
- cellular response to type II interferon
- receptor-mediated endocytosis
Molecular functions
- cargo receptor activity
- D-mannose binding
- signaling receptor activity
- transmembrane signaling receptor activity
- virus receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Fibronectin type II domain
- Ricin B, lectin domain
- C-type lectin-like
- Kringle-like fold
- C-type lectin-like/link domain superfamily
- C-type lectin fold
- C-type lectin, conserved site
- Ricin B-like lectins
- Fibronectin type II domain superfamily
- C-type lectin and snaclec domain-containing protein
- Fibronectin type II domain
- Lectin C-type domain
- MRC2-like, N-terminal cysteine-rich domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRC1 as an antibody target. Whether an autoantibody or antibody against MRC1 could matter depends on whether native MRC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRC1 is annotated at the cell surface, where native MRC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MRC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...